Cargando…
Overexpression of EGFR and TGFα in von Hippel–Lindau-Related Central Nervous System Hemangioblastomas
Background: Central nervous system (CNS) hemangioblastomas (HGBs) are the most frequent cause of mortality in patients with von Hippel–Lindau (VHL) disease. Characteristics of multiple and recurrent disease cause certain difficulties in the treatment of CNS HGBs. Methods: VHL-related HGB cases treat...
Autores principales: | Liu, Zhen, Li, Liang, Yi, Zhiqiang, Duan, Hongzhou, Lu, Runchun, Li, Chunwei, Zhou, Jingcheng, Gong, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214834/ https://www.ncbi.nlm.nih.gov/pubmed/32432044 http://dx.doi.org/10.3389/fonc.2020.00703 |
Ejemplares similares
-
Biological and clinical impact of central nervous system hemangioblastomas in Chinese patients with von Hippel-Lindau disease: implications for treatment
por: Liu, Zhen, et al.
Publicado: (2020) -
Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel–Lindau disease: case report
por: Liu, Zhen, et al.
Publicado: (2020) -
Disseminated Hemangioblastoma of the Central Nervous System without Von Hippel-Lindau Disease
por: Chung, Sun-Yoon, et al.
Publicado: (2014) -
Resection of von Hippel Lindau Related Brainstem Hemangioblastoma
por: Maggio, Dominic, et al.
Publicado: (2019) -
Mutations in the von Hippel-Lindau Tumour Suppressor Gene in Central Nervous System Hemangioblastomas
por: Cybulski, Cezary, et al.
Publicado: (2004)